Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor 4-fluoro-N-(2-hydroxyethyl)-N-(2-nitroso-2-oxoethyl)benzenesulfonamide Descriptor: 2-[(4-fluorophenyl)sulfonyl-(2-
AUC values for predicting drug-target interactions are shown to compare two cases of using experimentally validated interactions and by using all interactions including experiments, text mining, and o
Contact residues for the eight selected small molecules. All residues contain are within 4 Å of a ligand atom. Residues in bold are common to all six ligands.
